His research is focused on molecular imaging with PET and PET/MRI in cancer and his achievements include development of several new PET tracers that have reached first-in-human clinical use.
His research is focused on molecular imaging with PET and PET/MRI and targeted radionuclide therapies (theranostics) in cancer. His achievements include development of several new PET tracers that have reached first-in-human clinical use.